These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19307695)

  • 21. Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.
    Kutryb-Zajac B; Mateuszuk L; Zukowska P; Jasztal A; Zabielska MA; Toczek M; Jablonska P; Zakrzewska A; Sitek B; Rogowski J; Lango R; Slominska EM; Chlopicki S; Smolenski RT
    Cardiovasc Res; 2016 Nov; 112(2):590-605. PubMed ID: 28513806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methylnicotinamide protects against endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice.
    Jiang N; Wang M; Song J; Liu Y; Chen H; Mu D; Xia M
    Mol Nutr Food Res; 2016 Jul; 60(7):1625-36. PubMed ID: 26887666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse liver nicotinamide N-methyltransferase pharmacogenetics: biochemical properties and variation in activity among inbred strains.
    Scheller T; Orgacka H; Szumlanski CL; Weinshilboum RM
    Pharmacogenetics; 1996 Feb; 6(1):43-53. PubMed ID: 8845860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
    Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
    J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
    Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
    Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alleviation of fatty liver in a rat model by enhancing N
    Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine.
    Riederer M; Erwa W; Zimmermann R; Frank S; Zechner R
    Atherosclerosis; 2009 Jun; 204(2):412-7. PubMed ID: 18996527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.
    Ruf S; Hallur MS; Anchan NK; Swamy IN; Murugesan KR; Sarkar S; Narasimhulu LK; Putta VPRK; Shaik S; Chandrasekar DV; Mane VS; Kadnur SV; Suresh J; Bhamidipati RK; Singh M; Burri RR; Kristam R; Schreuder H; Czech J; Rudolph C; Marker A; Langer T; Mullangi R; Yura T; Gosu R; Kannt A; Dhakshinamoorthy S; Rajagopal S
    Bioorg Med Chem Lett; 2018 Mar; 28(5):922-925. PubMed ID: 29433927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional and Biochemical Endothelial Profiling
    Bar A; Olkowicz M; Tyrankiewicz U; Kus E; Jasinski K; Smolenski RT; Skorka T; Chlopicki S
    Front Pharmacol; 2017; 8():183. PubMed ID: 28443021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats.
    Zhao Y; Yang Y; Xing R; Cui X; Xiao Y; Xie L; You P; Wang T; Zeng L; Peng W; Li D; Chen H; Liu M
    Atherosclerosis; 2018 Apr; 271():26-35. PubMed ID: 29459263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional alterations in endothelial NO, PGI₂ and EDHF pathways in aorta in ApoE/LDLR-/- mice.
    Csányi G; Gajda M; Franczyk-Zarow M; Kostogrys R; Gwoźdź P; Mateuszuk L; Sternak M; Wojcik L; Zalewska T; Walski M; Chlopicki S
    Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):107-15. PubMed ID: 22465673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
    Chlopicki S; Swies J; Mogielnicki A; Buczko W; Bartus M; Lomnicka M; Adamus J; Gebicki J
    Br J Pharmacol; 2007 Sep; 152(2):230-9. PubMed ID: 17641676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.
    Kannt A; Rajagopal S; Kadnur SV; Suresh J; Bhamidipati RK; Swaminathan S; Hallur MS; Kristam R; Elvert R; Czech J; Pfenninger A; Rudolph C; Schreuder H; Chandrasekar DV; Mane VS; Birudukota S; Shaik S; Zope BR; Burri RR; Anand NN; Thakur MK; Singh M; Parveen R; Kandan S; Mullangi R; Yura T; Gosu R; Ruf S; Dhakshinamoorthy S
    Sci Rep; 2018 Feb; 8(1):3660. PubMed ID: 29483571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.
    Han SG; Howatt DA; Daugherty A; Gairola CG
    Toxicology; 2012 Sep; 299(2-3):133-8. PubMed ID: 22659316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR
    Kostogrys RB; Franczyk-Zarow M; Gasior-Glogowska M; Kus E; Jasztal A; Wrobel TP; Baranska M; Czyzynska-Cichon I; Drahun A; Manterys A; Chlopicki S
    Pharmacol Rep; 2017 Feb; 69(1):112-118. PubMed ID: 27915184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.